Expression of Nucleolar Antigen pl45 in Bone Marrow Cells of Patients with Myeloid Leukemias

Azra Raza, Suzan Imren, Sefer Gezer, Lev Verkh, James W. Freeman

Research output: Contribution to journalArticlepeer-review

6 Scopus citations


The expression of a cell cycle-related nucleolar protein (pl45) antigen was examined in the bone marrow aspirates of 45 individuals, three of whom had no malignant disease; 30 had a diagnosis of acute myeloid leukemia (AML), and 12 suffered from chronic myeloid leukemia (CML). While no evidence of pl45 expression was found in the three normal bone marrow samples, it was noted to be the highest in patients with active leukemia, be they AML or blastic crisis of CML. There was a direct correlation between the percentage of blasts and the percentage of pl45-positive cells in all patients. Double labeling with tritiated thymidine and pl45 in AML patients with active leukemia showed that the majority of S-phase cells contained pl45. Myeloblasts in both chronic phase and blastic crisis of CML expressed pl45. Nine of 12 AML patients studied during remission had less than 5% pl45-positive cells, but three showed 11%, 16%, and 33% positive cells. Since functionally/ morphologically, these marrows were normal, the appearance of pl45 may indicate a proliferative abnormality preceding maturation arrest and development of relapse. Thus we conclude that pl45 is more commonly associated with immature cells and may serve as an early indicator of relapse in AML, but requires further study with larger numbers of patients.

Original languageEnglish (US)
Pages (from-to)482-487
Number of pages6
JournalCancer Research
Issue number2
StatePublished - Jan 15 1989
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Expression of Nucleolar Antigen pl45 in Bone Marrow Cells of Patients with Myeloid Leukemias'. Together they form a unique fingerprint.

Cite this